The overarching goal of Beyond the 5 A’s is to improve the frequency and effectiveness of smoking cessation interventions provided by health professionals by improving the quality of training delivered to them on this critical topic. Beyond the 5 A’s brought together 167 professionals currently designing and delivering smoking cessation provider education programs, public health tobacco cessation experts, systems decision-makers, healthcare providers and researchers to translate recent advances in both evidence and practice into action that will improve the frequency and effectiveness of smoking cessation interventions.
Attendees examined recent advances in evidence and practice and discussed their own successful approaches, strategies, techniques and challenges to improving the effectiveness and quality of smoking cessation interventions delivered within healthcare settings. To learn more about the conference objectives, visit the About Us page.Wednesday, November 13, 2013
Independent Grants for Learning & Change* (IGLC) Grantees only
IGLC Grantee Pre-Conference Workshop
IGLC Grantees gathered on day one to strengthen their ties, reflect on their progress and challenges, and translate lessons learned into recommendations for quality training design and delivery.
Thursday & Friday, November 14-15, 2013
Through its unifying theme of improving training to providers on addressing tobacco use with their patients, days two and three engaged participants in new knowledge and discovery related to cessation interventions with specific populations, cessation delivery within specific health care settings and cessation delivery among specific types of providers.
* Independent Grants for Learning & Change
Pfizer offers support to independently run health care quality improvement initiatives through online resources and medical education grants.
An educational conference presented by National Jewish Health and the North American Quitline
Consortium in collaboration with the Smoking Cessation Leadership Center.
This educational activity is made possible by an unrestricted educational grant from Pfizer, Inc.